President Trump’s signature prescription drug platform launched February 5 with promises of historic savings. Seven weeks later, the results don’t match the launch claims.
TrumpRx.gov went live offering discounts on 40 branded medications — primarily GLP-1 weight-loss drugs, diabetes treatments, and fertility medications. The platform doesn’t sell drugs. It redirects cash-paying patients to manufacturer websites or prints discount coupons redeemable at pharmacies. Patients with insurance cannot use it; insurance deductibles are unaffected.
Independent pricing analysis found TrumpRx is not delivering lower prices than those paid in the United Kingdom. In some cases, U.S. prices through the platform run twice what comparable countries pay — the inverse of the most-favored-nation standard the executive order promised.
More than half the drugs listed already have cheaper generic versions available through Cost Plus Drugs, GoodRx, and other existing platforms.
A STAT News review published March 5 found that one month after launch, few additional drugs had been added, site traffic data remained undisclosed, and private deals with pharmaceutical companies were still being negotiated.
The platform does deliver real savings for a narrow population — uninsured or cash-paying patients on specific branded drugs. Ozempic dropped from $1,028 per month to an average of $350. Cetrotide, a fertility drug, fell from $316 to $22.50 per dose.
For the insured majority, Trump has called on Congress to pass his Great Healthcare Plan to extend those savings. The legislation has not been introduced.
Support Independent Local Journalism — High Country Advocate was created as a real alternative to regional media that too often silences dissenting voices while taking sides in the political struggle. Producing in-depth, unflinching reporting like this series and others is expensive: servers, editing, research time, and legal review all add up quickly. If these articles have informed you or given you new perspective, please consider supporting HCA with a paid subscription — every subscriber helps keep this reporting strong and independent. 